Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Alfa Wassermann Inc patents


Recent patent applications related to Alfa Wassermann Inc. Alfa Wassermann Inc is listed as an Agent/Assignee. Note: Alfa Wassermann Inc may have other listings under different names/spellings. We're not affiliated with Alfa Wassermann Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Alfa Wassermann Inc-related inventors


Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximin

Crystalline polymorphous forms of rifaximin (inn), referred to as rifaximin α and rifaximin β, and a poorly crystalline form referred to as rifaximin γ, useful in the production of medicaments containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a fixed temperature and for a fixed period of time, followed by a drying under controlled conditions until reaching a precise water content in the end product, are the object of the invention.. . ... Alfa Wassermann Inc

Polymorphic forms alpha, beta and gamma of rifaximin

Crystalline polymorphous forms of rifaximin (inn) antibiotic named rifaximin cc and rifaximin β, and a poorly crystalline form named rifaximin γ, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.. . ... Alfa Wassermann Inc

Fluid handling systems and method for ultracentrifuges

A fluid handling system is provided that includes a controller, a plurality of valves, a pump, and an interface in communication with the controller. The valves can be operatively connected with a conduit to along a flow path. ... Alfa Wassermann Inc

Centrifuge rotor core with partial channels

A rotor core is provided that includes a rotor length defined along an axis of rotation and a plurality of separation channels. The plurality of separation channels having a channel length extending along the axis of rotation a distance that is less than the rotor length. ... Alfa Wassermann Inc

Therapeutic and nutritional compositions for functional gastrointestinal disorders

The present invention relates to nutritional compositions containing balanced amount of substance having anti-inflammatory activity, as curcumin, and substance having carminative and spasmolytic activities, as essential plant oil, for the treatment and/or prevention of functional gastrointestinal disorders.. . ... Alfa Wassermann Inc

Polymorphic forms alpha, beta and gamma of rifaximin

Crystalline polymorphous forms of rifaximin (inn) antibiotic named rifaximin α and rifaximin β, and a poorly crystalline form named rifaximin γ, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.. . ... Alfa Wassermann Inc

Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximin

Crystalline polymorphous forms of rifaximin (inn), referred to as rifaximin α and rifaximin β, and a poorly crystalline form referred to as rifaximin γ, useful in the production of medicaments containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a fixed temperature and for a fixed period of time, followed by a drying under controlled conditions until reaching a precise water content in the end product, are the object of the invention.. . ... Alfa Wassermann Inc

Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof

The present invention relates to rifaximin compositions comprising amino acids, characterized in that they increase rifaximin solubility in aqueous solutions and are useful in the treatment of disease wherein amino acids and rifaximin are efficacious. The present invention also relates to pharmaceutical compositions comprising rifaximin or one of the pharmaceutically acceptable salts thereof and one or more amino acid(s), wherein the molar ratio between the amino acid(s) and rifaximin is from 1:1 to 10:1, together with pharmaceutically acceptable excipients. ... Alfa Wassermann Inc

Use of polyols to obtain stable polymorphous forms of rifaxmin

Polyols stabilize polymorphous form of rifaximin, in particular the β form. When polyols having at least two hydroxy groups are added to rifaximin powder, polymorph β is stable and remains stable in time independently from the environment humidity. ... Alfa Wassermann Inc

Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease

. . Disclosed herein are methods of treating a patient having an intestinal disorder, the methods comprising: administering to a patient in need thereof a pharmaceutical composition comprising a hydrate or solvate form of rifaximin in polymorphic form β, alone or in a mixture with other crystalline, hydrate, solvate or amorphous forms of rifaximin, in gastroresistant microgranules, wherein the rifaximin is administered at a dose of at least 800 mg per day for a period of at least 7 days.. . ... Alfa Wassermann Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Alfa Wassermann Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Alfa Wassermann Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###